The Effect of a Second Dose of Measles Vaccine at 18 Months of Age on Nonaccidental Deaths and Hospital Admissions in Guinea-Bissau: Interim Analysis of a Randomized Controlled Trial( )

BACKGROUND: The world is set on the eradication of measles. Continuation of the measles vaccine (MV) after eradication could still reduce morbidity because the MV has so-called beneficial nonspecific effects. We evaluated the effect of a “booster” dose of the MV on overall severe morbidity. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Berendsen, Mike L T, Silva, Isaquel, Balé, Carlitos, Nielsen, Sebastian, Hvidt, Sophus, Martins, Cesario L, Benn, Christine S, Aaby, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797043/
https://www.ncbi.nlm.nih.gov/pubmed/35218356
http://dx.doi.org/10.1093/cid/ciac155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797043/
https://www.ncbi.nlm.nih.gov/pubmed/35218356
http://dx.doi.org/10.1093/cid/ciac155

Ejemplares similares